| 44.91 BATS BZX Real-Time Price As of 10:05am ET |  -0.16 / -0.36%Today’s Change | 36.41 Today|||52-Week Range 46.01 | +17.53% Year-to-Date |
| Is Clovis Oncology Really a Buyout Candidate? Dec 03 / MotleyFool.com - Paid Partner Content | 3 Top Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content |
| Previous close | 45.07 |
| Today’s open | 45.07 |
| Day’s range | 44.91 - 45.09 |
| Volume | 974,647 |
| Average volume (3 months) | 2,505,437 |
| Market cap | $113.5B |
| Earnings growth (last year) | +143.10% |
| Earnings growth (this year) | +0.23% |
| Earnings growth (next 5 years) | +4.40% |
| Revenue growth (last year) | +5.72% |
| P/E ratio | 18.8 |
| Price/Sales | 2.31 |
| Price/Book | 20.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | -0.83 | -0.70% |
| SNYSanofi | -0.29 | -0.62% |
| NVONovo Nordisk | -0.17 | -0.30% |
| AZNAstraZeneca | -0.37 | -0.77% |
| Next reporting date | February 5, 2020 |
| EPS forecast (this quarter) | $0.69 |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $4.8B |
| Net profit margin | 11.75% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Brentford, Greater London |
